Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Wockhardt Group
Wockhardt Group
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Bevel edge or radius edge flat face tablets: Which is better for greater consumer acceptance?
Consumers and patients should perceive that their tablets are easy to swallow and devoid of any undesirable taste. Tablet manufacturers can influence acceptance of by producing...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Regulatory
Wockhardt becomes India's first to get regulatory nod for novel antibiotics
The Mumbai-based drugmaker prepares to launch EMROK in the domestic market
Infection Control
Wockhardt sets up manufacturing and R&D plant in Dubai
India's biotech and pharma company has built a 10,000 sqm facility for the production and packaging of sterile dry powder injection
Regulatory
Several large Indian pharma companies under US FDA scrutiny
Recent regulatory action by the FDA on leading Indian firms has affected the country's exports, according to Chairman of Dr. Reddy's Laboratories
Regulatory
US FDA to continue to target non-compliant Indian companies
All available enforcement tools to be utilised to bring facilities to compliance to ensure the protection of public health
Finance
Indian Big Pharma companies buck the global economic trend
India\'s top 25 pharma companies continue to go from strength to strength
Pharmaceutical
Indian manufacturers set to cash in on US generics market
Indian pharma companies are well positioned to generate strong revenues from the US generics market
Regulatory
Intellectual property battles rage on
Spate of cases filed recently shows that patent battles are heating up
Subscribe now